May 2003
Volume 44, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2003
Effects of Combined Treatment with Bunazosin Hydrochloride and Latanoprost on Intraocular Pressure in Monkeys
Author Affiliations & Notes
  • T. Akaishi
    Research and Development Division, Santen Pharmaceutical Co. Ltd, Ikoma, Japan
  • T. Matsugi
    Research and Development Division, Santen Pharmaceutical Co. Ltd, Ikoma, Japan
  • Y. Takagi
    Research and Development Division, Santen Pharmaceutical Co. Ltd, Ikoma, Japan
  • N. Ishida
    Research and Development Division, Santen Pharmaceutical Co. Ltd, Ikoma, Japan
  • H. Hara
    Research and Development Division, Santen Pharmaceutical Co. Ltd, Ikoma, Japan
  • K. Kashiwagi
    Department of Ophthalmology, University of Yamanashi Faculty of Medicine, Yamanashi, Japan
  • Footnotes
    Commercial Relationships  T. Akaishi, None; T. Matsugi, None; Y. Takagi, None; N. Ishida, None; H. Hara, None; K. Kashiwagi, None.
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science May 2003, Vol.44, 4388. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      T. Akaishi, T. Matsugi, Y. Takagi, N. Ishida, H. Hara, K. Kashiwagi; Effects of Combined Treatment with Bunazosin Hydrochloride and Latanoprost on Intraocular Pressure in Monkeys . Invest. Ophthalmol. Vis. Sci. 2003;44(13):4388.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: Bunazosin hydrochloride, a selective α1 adrenergic-receptor antagonist, reduces intraocular pressure (IOP) in glaucoma patients. This study evaluated the possible additive ocular hypotensive effects of bunazosin hydrochloride and latanoprost in ocular normotensive monkeys, and examined the effects of these two compounds on matrix metalloproteinase (MMP) activities in monkey cultured ciliary muscle cells. Methods: IOP was measured before and after instillation of bunazosin hydrochloride (0.01%) and latanoprost (0.005%) alone or in combination in ocular normotensive monkeys. Monkey ciliary muscle cells were grown to confluence in culture, then exposed to bunazosin hydrochloride (10-7 - 10-5 M) or latanoprost (10-6 M) for 72 hr. The activities of MMP-2, -3 and -9 in the medium were examined using gelatin and casein zymography. Results: The peak and maximal reduction in IOP of the combination of bunazosin hydrochloride and latanoprost were greater than those of bunazosin hydrochloride and latanoprost alone, respectively. Treatment with latanoprost increased MMP-2, -3 and -9 activities in the culture medium of ciliary muscle cells, but bunazosin hydrochloride did not. Conclusions: In ocular normotensive monkey, the combination of bunazosin hydrochloride and latanoprost has an effect on IOP that is greater than that of either drug given alone. Bunazosin hydrochloride reduced IOP without increasing MMP activities in ciliary muscle cells.

Keywords: intraocular pressure • outflow: ciliary muscle • pharmacology 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×